IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...
Interesting Engineering on MSN23h
Unlocking nuclear fusion at ITER: World’s largest reactor uses AI to boost efficiencyIn the southeastern region of France, a team of 2,000 physicists, scientists, and workers are busy building the world’s ...
MedUni Vienna physicians Daniel Aletaha and Josef Smolen have developed the Preferrix digital tool to enhance clinical trial ...
The Trump administration’s crackdown on foreign students and faculty who have voiced support for the Palestinian cause has ...
Secretary of State Marco Rubio said Thursday at least 300 foreign students have had their visas revoked amid the Trump ...
Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
David Megson from Manchester Metropolitan University in Manchester, UK, spoke to LCGC International about the latest ...
The National Institutes of Health (NIH) will no longer fund new research on how climate change affects people's health, according to records reviewed by ProPublica.
An arrests of an international students at Tufts and Columbia and heavy grant cuts are pressuring top minds to look outside ...
Spread the love Introduction Education is the cornerstone of societal progress, shaping the minds that will lead us into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback